Listed

Mesoblast Ltd: Form 20-F for the period ended Jun 30, 2018

Filed with the SEC on Aug 31, 2018 and accepted by EDGAR at Aug 31, 2018, 06:07 ET.

Share

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2018-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2017-07-01 to 2018-06-30$17.3mifrs-full:Revenue
Income tax12 months2017-07-01 to 2018-06-30−$30.7mifrs-full:IncomeTaxExpenseContinuingOperations
Net income12 months2017-07-01 to 2018-06-30−$35.3mifrs-full:ProfitLossAttributableToOwnersOfParent
Diluted EPS12 months2017-07-01 to 2018-06-30−$0.08ifrs-full:DilutedEarningsLossPerShare
Basic EPS12 months2017-07-01 to 2018-06-30−$0.08ifrs-full:BasicEarningsLossPerShare
Operating cash flow12 months2017-07-01 to 2018-06-30−$75.0mifrs-full:CashFlowsFromUsedInOperatingActivities
Cash and equivalentsAt period end2018-06-30$37.8mifrs-full:CashAndCashEquivalents
Current assetsAt period end2018-06-30$101.1mifrs-full:CurrentAssets
Total assetsAt period end2018-06-30$692.4mifrs-full:Assets
Current liabilitiesAt period end2018-06-30$24.0mifrs-full:CurrentLiabilities
Total liabilitiesAt period end2018-06-30$146.4mifrs-full:Liabilities
Shareholders' equityAt period end2018-06-30$546.0mifrs-full:Equity
Shares outstandingAt period end2018-06-30482,639,654 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001564590-18-022521. Last ingested by Listed: Oct 29, 2026, 06:58 ET. Listed shows no prices and gives no investment advice.